0001411617-18-000001.txt : 20181026 0001411617-18-000001.hdr.sgml : 20181026 20181026160236 ACCESSION NUMBER: 0001411617-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181026 DATE AS OF CHANGE: 20181026 EFFECTIVENESS DATE: 20181026 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Diasome Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001411617 IRS NUMBER: 263050656 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-324483 FILM NUMBER: 181141664 BUSINESS ADDRESS: STREET 1: 10000 CEDAR AVENUE STREET 2: SUITE 6 CITY: CLEVELAND STATE: OH ZIP: 44106 BUSINESS PHONE: 216-444-7110 MAIL ADDRESS: STREET 1: 10000 CEDAR AVENUE STREET 2: SUITE 6 CITY: CLEVELAND STATE: OH ZIP: 44106 FORMER COMPANY: FORMER CONFORMED NAME: Diasome Pharmaceuticals INC DATE OF NAME CHANGE: 20170113 FORMER COMPANY: FORMER CONFORMED NAME: Diasome Pharmaceuticals LLC DATE OF NAME CHANGE: 20070906 D 1 primary_doc.xml X0708 D LIVE 0001411617 Diasome Pharmaceuticals, Inc. 10000 CEDAR AVENUE SUITE 6 CLEVELAND OH OHIO 44106 216-444-7110 DELAWARE Diasome Pharmaceuticals INC Diasome Pharmaceuticals LLC Corporation true Robert Geho 10000 Cedar Avenue Suite 6 Cleveland OH OHIO 44106 Executive Officer Director W. Blair Geho 10000 Cedar Avenue Suite 6 Cleveland OH OHIO 44106 Director Thomas McDonald 10000 Cedar Avenue Suite 6 Cleveland OH OHIO 44106 Director Frank McCaney 10000 Cedar Avenue Suite 6 Cleveland OH OHIO 44106 Director Marc Penn 10000 Cedar Avenue Suite 6 Cleveland OH OHIO 44106 Director Biotechnology Decline to Disclose 06b false 2018-10-12 false true false 0 18638000 12084000 6554000 false 22 0 0 0 false Diasome Pharmaceuticals, Inc. /s/ Robert Geho Robert Geho Chief Executive Officer 2018-10-26